APA (7th ed.) Citation

A, M., MP, S., J, D., SM, B., JG, M., AP, P., . . . WO, C. (2025). Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: A pooled analysis of claims data. Frontiers in pharmacology, 16, 1693126. https://doi.org/10.3389/fphar.2025.1693126

Chicago Style (17th ed.) Citation

A, Mukhopadhyay, et al. "Hydroxyurea Utilization Among Individuals with Sickle Cell Disease in Tennessee: A Pooled Analysis of Claims Data." Frontiers in Pharmacology 16 (2025): 1693126. https://doi.org/10.3389/fphar.2025.1693126.

MLA (9th ed.) Citation

A, Mukhopadhyay, et al. "Hydroxyurea Utilization Among Individuals with Sickle Cell Disease in Tennessee: A Pooled Analysis of Claims Data." Frontiers in Pharmacology, vol. 16, 2025, p. 1693126, https://doi.org/10.3389/fphar.2025.1693126.